Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|9|3|417-428

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.3, 2011-09, pp. : 417-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood–Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability

By Tomizawa Y   Yokoyama K   Saiki S   Takahashi T   Matsuoka J   Hattori N  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1483-1491

Field House Publishing

Access to resources Recommend Favorite

Japanese encephalitis vaccine: Neuromyelitis optica: case report

By  

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Glatiramer acetate: Neuromyelitis optica relapse: case report

By  

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 60-70

Bentham Science Publishers

Access to resources Recommend Favorite

Etanercept: Multiple sclerosis and transverse myelitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite